Apellis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 12.22 M | $276.59 M | 0.00% | 9.70% |
| VANGUARD GROUP INC | 11/07/2025 | 9.99 M | $226.01 M | -1.65% | 7.93% |
| MORGAN STANLEY | 11/14/2025 | 9.64 M | $218.23 M | -1.12% | 7.65% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 9.29 M | $210.25 M | 3.50% | 7.37% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 8.00 M | $181.05 M | 14.29% | 6.35% |
| BLACKROCK, INC. | 11/12/2025 | 6.27 M | $141.86 M | -2.13% | 4.97% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 4.49 M | $101.55 M | -24.92% | 3.56% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 4.35 M | $98.40 M | 63.35% | 3.45% |
| STATE STREET CORP | 11/14/2025 | 4.04 M | $91.37 M | 13.33% | 3.20% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 3.45 M | $78.01 M | -71.02% | 2.74% |
| UBS GROUP AG | 11/13/2025 | 3.43 M | $77.62 M | -27.57% | 2.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.88 M | $65.13 M | 0.00% | 2.28% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 2.65 M | $59.97 M | 96.00% | 2.10% |
| SIREN, L.L.C. | 11/13/2025 | 2.58 M | $58.35 M | 0.00% | 2.05% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 2.32 M | $52.58 M | 56.74% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.07 M | $46.92 M | 3.89% | 1.64% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.50 M | $34.05 M | 0.55% | 1.19% |
| AMUNDI | 11/14/2025 | 1.49 M | $36.39 M | -6.88% | 1.19% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.48 M | $33.44 M | -39.11% | 1.17% |
| BANK OF NOVA SCOTIA | 11/14/2025 | 1.46 M | $32.95 M | 144.82% | 1.16% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.34 M | $30.41 M | 563.73% | 1.07% |
| ING GROEP NV | 11/06/2025 | 1.17 M | $26.58 M | 280.96% | 0.93% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 1.00 M | $22.63 M | 0.00% | 0.79% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 992.27 K | $22.46 M | 111.70% | 0.79% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 972.47 K | $22.01 M | -25.11% | 0.77% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 903.50 K | $20.45 M | 0.00% | 0.72% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 808.61 K | $18.30 M | 100.00% | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 722.90 K | $16.36 M | 6,478.95% | 0.57% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 717.70 K | $16.24 M | -4.33% | 0.57% |
| NUVEEN, LLC | 11/12/2025 | 665.05 K | $15.05 M | 41.72% | 0.53% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 647.08 K | $14.64 M | -34.58% | 0.51% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 620.79 K | $14.05 M | 100.00% | 0.49% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 600.40 K | $13.59 M | 16.58% | 0.48% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 586.94 K | $13.28 M | 79.26% | 0.47% |
| CITADEL ADVISORS LLC | 11/14/2025 | 586.45 K | $13.27 M | 32.51% | 0.47% |
| OSSIAM | 11/14/2025 | 555.95 K | $12.58 M | 0.00% | 0.44% |
| NORTHERN TRUST CORP | 11/14/2025 | 549.25 K | $12.43 M | 4.44% | 0.44% |
| WOODLINE PARTNERS LP | 11/14/2025 | 542.98 K | $12.29 M | 2.27% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 469.00 K | $10.61 M | -9.25% | 0.37% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 456.79 K | $10.34 M | 81.94% | 0.36% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 451.90 K | $10.23 M | 502.54% | 0.36% |
| CITIGROUP INC | 11/10/2025 | 444.97 K | $10.07 M | 221.39% | 0.35% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 418.50 K | $9.47 M | -11.89% | 0.33% |
| SG AMERICAS SECURITIES, LLC | 10/23/2025 | 417.39 K | $9.45 M | 825.42% | 0.33% |
| MARSHALL WACE, LLP | 11/13/2025 | 396.74 K | $8.98 M | -85.33% | 0.31% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 363.45 K | $8.23 M | 4.34% | 0.29% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 358.00 K | $8.10 M | 100.00% | 0.28% |
| HRT FINANCIAL LP | 11/14/2025 | 353.65 K | $8.00 M | 229.90% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 313.88 K | $7.10 M | -4.52% | 0.25% |
| J. GOLDMAN & CO LP | 11/14/2025 | 306.90 K | $6.95 M | 87.71% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apellis Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 369 institutional investors and hedge funds held shares of Apellis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Avoro Capital Advisors LLC: 12.22 M
VANGUARD GROUP INC: 9.99 M
MORGAN STANLEY: 9.64 M
WELLINGTON MANAGEMENT GROUP LLP: 9.29 M
Deep Track Capital, LP: 8 M
BlackRock, Inc.: 6.27 M
97.22% of Apellis Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 138.04 M shares in the last 24 months. This purchase volume represents approximately $3.29 B in transactions.